This company listing is no longer active
Aleafia Health Future Growth
Future criteria checks 0/6
We currently don't have sufficient analyst coverage to forecast growth and revenue for Aleafia Health.
Key information
n/a
Earnings growth rate
n/a
EPS growth rate
| Pharmaceuticals earnings growth | 53.6% |
| Revenue growth rate | n/a |
| Future return on equity | n/a |
| Analyst coverage | None |
| Last updated | n/a |
Recent future growth updates
Recent updates
Fewer Investors Than Expected Jumping On Aleafia Health Inc. (TSE:AH)
Apr 19
Why Aleafia Health Inc. (TSE:AH) Could Be Worth Watching
Jan 04CA$0.29: That's What Analysts Think Aleafia Health Inc. (TSE:AH) Is Worth After Its Latest Results
Feb 17Analysts Are Betting On Aleafia Health Inc. (TSE:AH) With A Big Upgrade This Week
Feb 16Here's Why Aleafia Health (TSE:AH) Can Afford Some Debt
Nov 10Analysts Expect Aleafia Health Inc. (TSE:AH) To Breakeven Soon
Feb 26Introducing Aleafia Health (TSE:AH), A Stock That Climbed 29% In The Last Year
Jan 22
Would Aleafia Health (TSE:AH) Be Better Off With Less Debt?
Dec 18In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Aleafia Health has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.
This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.
Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 3/31/2023 | 43 | -35 | -5 | -3 | N/A |
| 12/31/2022 | 38 | -12 | 4 | 6 | N/A |
| 9/30/2022 | 36 | -58 | -16 | -13 | N/A |
| 6/30/2022 | 36 | -146 | -22 | -20 | N/A |
| 3/31/2022 | 34 | -136 | -29 | -26 | N/A |
| 12/31/2021 | 36 | -166 | -37 | -33 | N/A |
| 9/30/2021 | 43 | -312 | -39 | -36 | N/A |
| 6/30/2021 | 38 | -248 | -39 | -32 | N/A |
| 3/31/2021 | 37 | -252 | -27 | -17 | N/A |
| 12/31/2020 | 36 | -256 | -25 | -8 | N/A |
| 9/30/2020 | 35 | -40 | -30 | -10 | N/A |
| 6/30/2020 | 35 | -18 | -34 | -12 | N/A |
| 3/31/2020 | 29 | -26 | -52 | -28 | N/A |
| 12/31/2019 | 16 | -40 | -54 | -38 | N/A |
| 9/30/2019 | 11 | -42 | -49 | -36 | N/A |
| 6/30/2019 | 7 | -47 | -48 | -29 | N/A |
| 3/31/2019 | 5 | -37 | -31 | -19 | N/A |
| 12/31/2018 | 3 | -19 | -22 | -10 | N/A |
| 9/30/2018 | 3 | -8 | -16 | -4 | N/A |
| 6/30/2018 | 1 | -5 | -4 | -3 | N/A |
| 3/31/2018 | 0 | -4 | -3 | -3 | N/A |
| 12/31/2017 | 0 | -11 | -1 | -1 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: Insufficient data to determine if AH's forecast earnings growth is above the savings rate (1.9%).
Earnings vs Market: Insufficient data to determine if AH's earnings are forecast to grow faster than the Canadian market
High Growth Earnings: Insufficient data to determine if AH's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: Insufficient data to determine if AH's revenue is forecast to grow faster than the Canadian market.
High Growth Revenue: Insufficient data to determine if AH's revenue is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if AH's Return on Equity is forecast to be high in 3 years time